Previous Next Accountability Senators Who Led Pharma-Friendly Patent Reform Also Prime Targets For Pharma Cash Abstract: Three senators on a revived subcommittee received more than $100,000 each from drugmakers. Publication: Kaiser Health News Date Published: March 24, 2020 Author(s): Emmarie Huetteman View This Resource